US Centers for Disease Control and Prevention said on Thursday that it was tracking a new, highly mutated lineage of the virus that causes COVID-19.
The lineage is named BA.2.86, and has been detected in the United States, Denmark and Israel, the CDC said in a post on messaging platform X. Since the CDC’s statement, an additional case of the variant was detected in the UK, according to Luke Blagdon Snell, a clinical research fellow at King’s College London. The sample collected in the UK was most similar to samples collected in Denmark, according to Snell.
Looks like we have 5th case of new, highly mutated Omicron variant, BA.2.86 in London UK @GSTTnhs. First identified by @shay_fleishon in Israel on 13 Aug.Our case: Hospitalised, Symptoms 13Aug, locally acquired.Sending to @KCLImmunoMicro for culture.EPI_ISL_18111770
— Luke Blagdon Snell (@lukebsnell) August 18, 2023
“As we learn more about BA.2.86, CDC’s advice on protecting yourself from COVID-19 remains the same,” the agency said.
The World Health Organization (WHO) earlier on Thursday said in a post on X that it had classified BA.2.86 as a “variant under monitoring” due to the large number of mutations it carries.
WHO has designated #COVID19 variant BA.2.86 as a ‘variant under monitoring’ today due to the large number of mutations it carries.So far, only a few sequences of the variant have been reported from a handful of countries. https://t.co/3tJkDZdY1V
— World Health Organization (WHO) (@WHO) August 17, 2023
The WHO said that, so far, only a few sequences of the variant have been reported from a handful of countries.
BA.2.86 strain ‘harkens back to an earlier branch’
The new lineage, which has 36 mutations from the currently-dominant XXB.1.5 COVID variant “harkens back to an earlier branch” of the virus, explained Dr. S. Wesley Long, medical director of diagnostic microbiology at Houston Methodist.
He said it remains to be seen whether BB.2.86 will be able to out-compete other strains of the virus or have any advantage in escaping immune responses from prior infection or vaccination.
Early analysis indicates that the new variant “will have equal or greater escape than XXB.1.5 from antibodies elicited by pre-Omicron and first-generation Omicron variants,” Jesse Bloom, a virologist at the Fred Hutch Cancer Center said in a slide deck published on Thursday.
The Omicron subvariant XBB.1.5 is the strain targeted by vaccines in upcoming COVID booster shots.
Bloom’s slides note that the most likely scenario is that BA.2.86 is less transmissible than current dominant variants, so never spreads widely, but more sequencing data is needed.
“My biggest concern would be that it could cause a bigger spike in cases than what we have seen in recent waves,” Dr. Long said. “The boosters will still help you fight off COVID in general.”
Jerusalem Post Staff contributed to this report.